John S Giuliano1, Barry P Markovitz, Joe Brierley, Richard Levin, Gary Williams, Lucy Chai See Lum, Tavey Dorofaeff, Pablo Cruces, Jenny L Bush, Luke Keele, Vinay M Nadkarni, Neal J Thomas, Julie C Fitzgerald, Scott L Weiss. 1. 1Division of Critical Care Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT. 2Division of Pediatric Critical Care, Departments of Pediatrics and Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA. 3Department of Critical Care and Bioethics, Great Ormond Street Hospital NHS Trust, London, United Kingdom. 4Department of Pediatrics, Royal Hospital for Children, Glasgow, Scotland. 5Intensive Care Department, Sydney Children's Hospital, Randwick, NSW, Australia. 6Department of Pediatrics, University of Malaya Medical Center, Kuala Lumpur, Malaysia. 7Paediatric Intensive Care Unit, Division of Paediatric Critical Care, Department of Pediatrics, Lady Cilento Children's Hospital, Brisbane, QLD, Australia. 8Department of Pediatric Intensive Care, Hospital El Carmen de Maipu, Universidad Andres Bello, Santiago, Chile. 9Division of Critical Care Medicine, Department of Anesthesia and Critical Care, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 10Department of Political Science, Penn State University, University Park, PA. 11Division of Pediatric Critical Care Medicine, Department of Pediatrics, Penn State Hershey Children's Hospital, Penn State University College of Medicine, Hershey, PA.
Abstract
OBJECTIVES: Pediatric severe sepsis remains a significant global health problem without new therapies despite many multicenter clinical trials. We compared children managed with severe sepsis in European and U.S. PICUs to identify geographic variation, which may improve the design of future international studies. DESIGN: We conducted a secondary analysis of the Sepsis PRevalence, OUtcomes, and Therapies study. Data about PICU characteristics, patient demographics, therapies, and outcomes were compared. Multivariable regression models were used to determine adjusted differences in morbidity and mortality. SETTING: European and U.S. PICUs. PATIENTS: Children with severe sepsis managed in European and U.S. PICUs enrolled in the Sepsis PRevalence, OUtcomes, and Therapies study. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: European PICUs had fewer beds (median, 11 vs 24; p < 0.001). European patients were younger (median, 1 vs 6 yr; p < 0.001), had higher severity of illness (median Pediatric Index of Mortality-3, 5.0 vs 3.8; p = 0.02), and were more often admitted from the ward (37% vs 24%). Invasive mechanical ventilation, central venous access, and vasoactive infusions were used more frequently in European patients (85% vs 68%, p = 0.002; 91% vs 82%, p = 0.05; and 71% vs 50%; p < 0.001, respectively). Raw morbidity and mortality outcomes were worse for European compared with U.S. patients, but after adjusting for patient characteristics, there were no significant differences in mortality, multiple organ dysfunction, disability at discharge, length of stay, or ventilator/vasoactive-free days. CONCLUSIONS: Children with severe sepsis admitted to European PICUs have higher severity of illness, are more likely to be admitted from hospital wards, and receive more intensive care therapies than in the United States. The lack of significant differences in morbidity and mortality after adjusting for patient characteristics suggests that the approach to care between regions, perhaps related to PICU bed availability, needs to be considered in the design of future international clinical trials in pediatric severe sepsis.
OBJECTIVES: Pediatric severe sepsis remains a significant global health problem without new therapies despite many multicenter clinical trials. We compared children managed with severe sepsis in European and U.S. PICUs to identify geographic variation, which may improve the design of future international studies. DESIGN: We conducted a secondary analysis of the Sepsis PRevalence, OUtcomes, and Therapies study. Data about PICU characteristics, patient demographics, therapies, and outcomes were compared. Multivariable regression models were used to determine adjusted differences in morbidity and mortality. SETTING: European and U.S. PICUs. PATIENTS: Children with severe sepsis managed in European and U.S. PICUs enrolled in the Sepsis PRevalence, OUtcomes, and Therapies study. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: European PICUs had fewer beds (median, 11 vs 24; p < 0.001). European patients were younger (median, 1 vs 6 yr; p < 0.001), had higher severity of illness (median Pediatric Index of Mortality-3, 5.0 vs 3.8; p = 0.02), and were more often admitted from the ward (37% vs 24%). Invasive mechanical ventilation, central venous access, and vasoactive infusions were used more frequently in European patients (85% vs 68%, p = 0.002; 91% vs 82%, p = 0.05; and 71% vs 50%; p < 0.001, respectively). Raw morbidity and mortality outcomes were worse for European compared with U.S. patients, but after adjusting for patient characteristics, there were no significant differences in mortality, multiple organ dysfunction, disability at discharge, length of stay, or ventilator/vasoactive-free days. CONCLUSIONS:Children with severe sepsis admitted to European PICUs have higher severity of illness, are more likely to be admitted from hospital wards, and receive more intensive care therapies than in the United States. The lack of significant differences in morbidity and mortality after adjusting for patient characteristics suggests that the approach to care between regions, perhaps related to PICU bed availability, needs to be considered in the design of future international clinical trials in pediatric severe sepsis.
Authors: Jonathan Cohen; Jean-Louis Vincent; Neill K J Adhikari; Flavia R Machado; Derek C Angus; Thierry Calandra; Katia Jaton; Stefano Giulieri; Julie Delaloye; Steven Opal; Kevin Tracey; Tom van der Poll; Eric Pelfrene Journal: Lancet Infect Dis Date: 2015-04-19 Impact factor: 25.071
Authors: Mirjana Cvetkovic; Daniel Lutman; Padmanabhan Ramnarayan; Nazima Pathan; David P Inwald; Mark J Peters Journal: Pediatr Crit Care Med Date: 2015-06 Impact factor: 3.624
Authors: Scott L Weiss; Julie C Fitzgerald; John Pappachan; Derek Wheeler; Juan C Jaramillo-Bustamante; Asma Salloo; Sunit C Singhi; Simon Erickson; Jason A Roy; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas Journal: Am J Respir Crit Care Med Date: 2015-05-15 Impact factor: 21.405
Authors: Juan C Jaramillo-Bustamante; Alejandro Marín-Agudelo; Mauricio Fernández-Laverde; José Bareño-Silva Journal: Pediatr Crit Care Med Date: 2012-09 Impact factor: 3.624
Authors: Stéphane Leteurtre; Alain Martinot; Alain Duhamel; François Proulx; Bruno Grandbastien; Jacques Cotting; Ronald Gottesman; Ari Joffe; Jurg Pfenninger; Philippe Hubert; Jacques Lacroix; Francis Leclerc Journal: Lancet Date: 2003-07-19 Impact factor: 79.321
Authors: Mitchell M Levy; Antonio Artigas; Gary S Phillips; Andrew Rhodes; Richard Beale; Tiffany Osborn; Jean-Louis Vincent; Sean Townsend; Stanley Lemeshow; R Phillip Dellinger Journal: Lancet Infect Dis Date: 2012-10-26 Impact factor: 25.071
Authors: Haidong Wang; Chelsea A Liddell; Matthew M Coates; Meghan D Mooney; Carly E Levitz; Austin E Schumacher; Henry Apfel; Marissa Iannarone; Bryan Phillips; Katherine T Lofgren; Logan Sandar; Rob E Dorrington; Ivo Rakovac; Troy A Jacobs; Xiaofeng Liang; Maigeng Zhou; Jun Zhu; Gonghuan Yang; Yanping Wang; Shiwei Liu; Yichong Li; Ayse Abbasoglu Ozgoren; Semaw Ferede Abera; Ibrahim Abubakar; Tom Achoki; Ademola Adelekan; Zanfina Ademi; Zewdie Aderaw Alemu; Peter J Allen; Mohammad AbdulAziz AlMazroa; Elena Alvarez; Adansi A Amankwaa; Azmeraw T Amare; Walid Ammar; Palwasha Anwari; Solveig Argeseanu Cunningham; Majed Masoud Asad; Reza Assadi; Amitava Banerjee; Sanjay Basu; Neeraj Bedi; Tolesa Bekele; Michelle L Bell; Zulfiqar Bhutta; Jed D Blore; Berrak Bora Basara; Soufiane Boufous; Nicholas Breitborde; Nigel G Bruce; Linh Ngoc Bui; Jonathan R Carapetis; Rosario Cárdenas; David O Carpenter; Valeria Caso; Ruben Estanislao Castro; Ferrán Catalá-Lopéz; Alanur Cavlin; Xuan Che; Peggy Pei-Chia Chiang; Rajiv Chowdhury; Costas A Christophi; Ting-Wu Chuang; Massimo Cirillo; Iuri da Costa Leite; Karen J Courville; Lalit Dandona; Rakhi Dandona; Adrian Davis; Anand Dayama; Kebede Deribe; Samath D Dharmaratne; Mukesh K Dherani; Uğur Dilmen; Eric L Ding; Karen M Edmond; Sergei Petrovich Ermakov; Farshad Farzadfar; Seyed-Mohammad Fereshtehnejad; Daniel Obadare Fijabi; Nataliya Foigt; Mohammad H Forouzanfar; Ana C Garcia; Johanna M Geleijnse; Bradford D Gessner; Ketevan Goginashvili; Philimon Gona; Atsushi Goto; Hebe N Gouda; Mark A Green; Karen Fern Greenwell; Harish Chander Gugnani; Rahul Gupta; Randah Ribhi Hamadeh; Mouhanad Hammami; Hilda L Harb; Simon Hay; Mohammad T Hedayati; H Dean Hosgood; Damian G Hoy; Bulat T Idrisov; Farhad Islami; Samaya Ismayilova; Vivekanand Jha; Guohong Jiang; Jost B Jonas; Knud Juel; Edmond Kato Kabagambe; Dhruv S Kazi; Andre Pascal Kengne; Maia Kereselidze; Yousef Saleh Khader; Shams Eldin Ali Hassan Khalifa; Young-Ho Khang; Daniel Kim; Yohannes Kinfu; Jonas M Kinge; Yoshihiro Kokubo; Soewarta Kosen; Barthelemy Kuate Defo; G Anil Kumar; Kaushalendra Kumar; Ravi B Kumar; Taavi Lai; Qing Lan; Anders Larsson; Jong-Tae Lee; Mall Leinsalu; Stephen S Lim; Steven E Lipshultz; Giancarlo Logroscino; Paulo A Lotufo; Raimundas Lunevicius; Ronan Anthony Lyons; Stefan Ma; Abbas Ali Mahdi; Melvin Barrientos Marzan; Mohammad Taufiq Mashal; Tasara T Mazorodze; John J McGrath; Ziad A Memish; Walter Mendoza; George A Mensah; Atte Meretoja; Ted R Miller; Edward J Mills; Karzan Abdulmuhsin Mohammad; Ali H Mokdad; Lorenzo Monasta; Marcella Montico; Ami R Moore; Joanna Moschandreas; William T Msemburi; Ulrich O Mueller; Magdalena M Muszynska; Mohsen Naghavi; Kovin S Naidoo; K M Venkat Narayan; Chakib Nejjari; Marie Ng; Jean de Dieu Ngirabega; Mark J Nieuwenhuijsen; Luke Nyakarahuka; Takayoshi Ohkubo; Saad B Omer; Angel J Paternina Caicedo; Victoria Pillay-van Wyk; Dan Pope; Farshad Pourmalek; Dorairaj Prabhakaran; Sajjad U R Rahman; Saleem M Rana; Robert Quentin Reilly; David Rojas-Rueda; Luca Ronfani; Lesley Rushton; Mohammad Yahya Saeedi; Joshua A Salomon; Uchechukwu Sampson; Itamar S Santos; Monika Sawhney; Jürgen C Schmidt; Marina Shakh-Nazarova; Jun She; Sara Sheikhbahaei; Kenji Shibuya; Hwashin Hyun Shin; Kawkab Shishani; Ivy Shiue; Inga Dora Sigfusdottir; Jasvinder A Singh; Vegard Skirbekk; Karen Sliwa; Sergey S Soshnikov; Luciano A Sposato; Vasiliki Kalliopi Stathopoulou; Konstantinos Stroumpoulis; Karen M Tabb; Roberto Tchio Talongwa; Carolina Maria Teixeira; Abdullah Sulieman Terkawi; Alan J Thomson; Andrew L Thorne-Lyman; Hideaki Toyoshima; Zacharie Tsala Dimbuene; Parfait Uwaliraye; Selen Begüm Uzun; Tommi J Vasankari; Ana Maria Nogales Vasconcelos; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Stephen Waller; Xia Wan; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Ronny Westerman; James D Wilkinson; Hywel C Williams; Yang C Yang; Gokalp Kadri Yentur; Paul Yip; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Kim Yun Jin; Maysaa El Sayed Zaki; Shankuan Zhu; Theo Vos; Alan D Lopez; Christopher J L Murray Journal: Lancet Date: 2014-05-02 Impact factor: 79.321
Authors: Li Liu; Shefali Oza; Daniel Hogan; Jamie Perin; Igor Rudan; Joy E Lawn; Simon Cousens; Colin Mathers; Robert E Black Journal: Lancet Date: 2014-09-30 Impact factor: 79.321
Authors: Ericka L Fink; Patrick M Kochanek; Robert C Tasker; John Beca; Michael J Bell; Robert S B Clark; Jamie Hutchison; Monica S Vavilala; Anthony Fabio; Derek C Angus; R Scott Watson Journal: Pediatr Crit Care Med Date: 2017-04 Impact factor: 3.624